The WACC of Neovacs SA (ALNEV.PA) is 5.6%.
| Range | Selected | |
| Cost of equity | 5.40% - 8.80% | 7.10% |
| Tax rate | 8.70% - 12.80% | 10.75% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 4.9% - 6.2% | 5.6% |
| Category | Low | High |
| Long-term bond rate | 3.0% | 3.5% |
| Equity market risk premium | 5.8% | 6.8% |
| Adjusted beta | 0.41 | 0.7 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 5.40% | 8.80% |
| Tax rate | 8.70% | 12.80% |
| Debt/Equity ratio | 1.4 | 1.4 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 4.9% | 6.2% |
| Selected WACC | 5.6% | |